• Home
  • About
  • Issues
    • Column 1
      • Energy
      • Healthcare
      • Taxes & Spending
      • Technology
      • Consumer Safety
    • Column 2
      • Agriculture
      • Trade
      • Government Regulation
      • Banking & Investmets
      • Intellectual Property
    • Column 3
      • Property Rights
      • Legal Reform
      • Higher Education
      • Right To Work
      • Retail & Online Commerce
  • Newsroom
  • Contact
info@caseforconsumers.org
Case for ConsumersCase for Consumers
Case for ConsumersCase for Consumers
  • Home
  • About
  • Issues
    • Column 1
      • Energy
      • Healthcare
      • Taxes & Spending
      • Technology
      • Consumer Safety
    • Column 2
      • Agriculture
      • Trade
      • Government Regulation
      • Banking & Investmets
      • Intellectual Property
    • Column 3
      • Property Rights
      • Legal Reform
      • Higher Education
      • Right To Work
      • Retail & Online Commerce
  • Newsroom
  • Contact

Healthcare

Introduction ¦ ACA Reform ¦  PBM/Pharmaceutical Reform ¦  CASE Media


Introduction

Government encroachment into Americans’ healthcare has been nothing short of a disaster, resulting in skyrocketing premiums, higher treatment costs, fewer options, and disincentives for doctors to provide care. CASE believes in both the sanctity of the doctor/patient relationship, and a healthcare market which allows consumers to make informed choices about how best to tend to their medical needs. Obamacare failed with its top-down and one-size-fits-all approach to healthcare. Real healthcare reform involves removing barriers that prevent healthcare and insurance providers from offering the widest choice of options to the greatest number of consumers. When Americans’ lives and well-being are at stake, consumers should be empowered to choose the healthcare services and providers that work best for them, not what government bureaucrats dictate.

America spends $3.2 trillion on healthcare in a year, or about $10,000 for every man, woman, and child in the country. That also amounts to about 18% of our total gross domestic product. Of that, spending on federal government Medicare is $648 billion, and spending on state and federal Medicaid is $574 billion. Slowly but surely, America is going broke paying for healthcare.

Do we have a free market for healthcare in America? The answer is no, we do not. We didn’t have a free market for healthcare BEFORE the Patient Protection and Affordable Care Act [ACA] was passed and we don’t have a free market for healthcare WITH the ACA. Furthermore, we won’t have a free market for healthcare AFTER –  if Congress only repeals the ACA. We will need to take further steps to get government out of the healthcare business.

These are the key areas where CASE believes consumers can, for the first time since World War II, be put at the center restoring free market principles to the healthcare and health insurance industries in America:

 


Patient Protection and Affordable Care Act Reform. Here is the comprehensive overview of how we can put consumers at the center of restoring free market principles to America’s healthcare and health insurance system. The CASE for Healthcare Reform for Consumers.

 

 


Pharmacy Benefit Managers [PBMs] and the cost of pharmaceuticals. There is mounting evidence that the role of PBMs distorts drug prices and is a driver of higher drug costs. As spikes in prescription drug prices occur without justification, we believe we need more transparency to protect patients from drug price gouging and manipulation. There is a need for greater transparency among pharmaceutical manufacturers, pharmacy benefit managers and health plans will shed light on the rationale for drug price increases and why patients pay what they do for their medications. CASE opposes provisions in pharmacies’ contracts with PBMs that prohibit pharmacists from disclosing that a patient’s co-pay is higher than the drug’s cash price.

 


CASE Media on Healthcare. Here are the articles and op-eds CASE has written on healthcare.

  • CASE Statement on Obamacare Incentives Create Hospital Monopolies Putting Profits Ahead of Patients, 11/22/2017
  • CASE Statement on CHIP Reauthorization, 11/2/2017
  • CASE Op-ED, PBM Reform Could Save Consumers Millions on Prescription Drugs, 10/19/2017
  • CASE Op-Ed, Hospital Consolidation Demands Closer Scrutiny, 9/11/2017

Search

Categories

  • Aegis
  • Agriculture
  • Commerce
  • Communications
  • Consumer Safety
  • Data Privacy
  • Economy
  • Education
  • Energy
  • Entertainment
  • Environment
  • Financial Services
  • Fiscal Policy
  • Healthcare
  • Higher Ed on the Hill
  • Housing
  • Intellectual Property
  • Kentucky
  • Labor
  • Legal
  • Lifestyle
  • Manufacturing
  • Media
  • Regulation
  • Retail
  • Robotexts
  • Taxes
  • TCPA
  • Technology
  • Ticketmaster
  • Trade
  • Transportation
  • Uncategorized
  • Veterans

Archives

Contact Us

CASE Follow

Consumer Action for a Strong Economy - the Free Market Voice for America's Consumers; likes=bookmarks

CASE_forAmerica
case_foramerica CASE @case_foramerica ·
23 Oct

.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.

Reply on Twitter 1849183731690409996 Retweet on Twitter 1849183731690409996 5 Like on Twitter 1849183731690409996 4 Twitter 1849183731690409996
Retweet on Twitter CASE Retweeted
case_foramerica CASE @case_foramerica ·
23 Oct

Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.

By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!

Reply on Twitter 1849132991164874848 Retweet on Twitter 1849132991164874848 6 Like on Twitter 1849132991164874848 2 Twitter 1849132991164874848
Retweet on Twitter CASE Retweeted
case_foramerica CASE @case_foramerica ·
21 Oct

CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/

Reply on Twitter 1848386046033010802 Retweet on Twitter 1848386046033010802 4 Like on Twitter 1848386046033010802 2 Twitter 1848386046033010802
case_foramerica CASE @case_foramerica ·
23 Oct

Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.

By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!

Reply on Twitter 1849132991164874848 Retweet on Twitter 1849132991164874848 6 Like on Twitter 1849132991164874848 2 Twitter 1849132991164874848
Load More

Contact us for more information!

Send us an email so that we can get back to you, as soon as possible.

Send Message
Find out more about consumer issues View Issues

Find us here

  • Case for Consumers
  • 1800 Diagonal Road, Suite 600 Alexandria, VA 22314
  • 703-718-5011
  • info@caseforconsumers.org
  • caseforconsumers.org

Fresh from our blog

  • CASE Op-Ed in RealClearPolicy: Foreign Patent Trolls Wreak Havoc at the ITC
  • Victory for American Energy: Rep. Newhouse’s Leadership Secures Nuclear Tax Credits in Trump’s Big, Beautiful Bill
  • Sen. Tillis Bill Will End the Trial Lawyer Gravy Train
  • CASE Op-Ed in American Thinker: Crypto Kiosks Unfairly Singled Out By Lawmakers

© 2025 · Case for Consumers

  • Home
  • About
  • Issues
  • Contact
  • Privacy policy
  • Terms & Condition